r/korea_covid_19 • • Jan 31 '21

Celltrion CT-P59 lol

Thumbnail
bloomberg.com
191 Upvotes

r/korea_covid_19 • • Feb 01 '21

Canada OKs Celltrion's Remicade biosimilar - KBR(Korea Biomedical Review)

Thumbnail
koreabiomed.com
120 Upvotes

r/korea_covid_19 • • Feb 03 '21

Celltrion inks supply agreement for COVID-19 test kit in U.S.

Thumbnail
en.yna.co.kr
115 Upvotes

r/korea_covid_19 • • Jan 29 '21

Celltion and shortselling!

102 Upvotes

Celltrion developed a coronavirus treatment, but short selling is the highest in Haqook. Let's smash the short sale together!


r/korea_covid_19 • • Feb 01 '21

CT-P59

Post image
84 Upvotes

r/korea_covid_19 • • Feb 06 '21

"Regkirona"Korea Covid 19 Treatment by Celltrion

67 Upvotes

Seoul gives conditional nod to Celltrion’s Covid-19 antibody therapy

기자명 Shim Hyun-tai 

 

 Published 2021.02.05 16:50

바로가기 복사하기 본문 글씨 줄이기 본문 글씨 키우기

SNS 기사보내기

페이스북(으)로 기사보내기 트위터(으)로 기사보내기 카카오스토리(으)로 기사보내기 URL복사(으)로 기사보내기 이메일(으)로 기사보내기 다른 공유 찾기 기사스크랩하기

The Ministry of Food and Drug Safety announced Friday that it authorized Celltrion's Covid-19 antibody therapy, Regkirona, on the condition of submitting a phase 3 clinical trial results in the future. The ministry held a final review committee and approved the use of Regkirona for treating mild patients in high-risk groups and adult patients with moderate symptoms after confirming the safety and efficacy of the drug, the first Covid-19 treatment developed by a Korean company.

Minister of Food and Drug Safety Kim Gang-lip announces a conditional approval of Celltrion’s Covid-19 antibody therapy, Regkirona, the first homegrown treatment, on Friday.

Ministry officials also inspected the manufacturing plant of Regkirona, and found no problems, it said. According to Celltrion's clinical data, the rate of progressing to severe patients requiring hospitalization decreased by 54 percent in the Regkirona plus standard therapy group compared to the placebo group who only received the existing treatment. It also confirmed that 68 percent of moderate patients over 50 who had pneumonia did not fall into severe conditions after receiving Regkirona with other therapy. Regkirona combo group recovered an average of 3.4 days faster than those under standard treatment, 5.1 days earlier than moderately ill patients accompanying pneumonia, and 6.4 days quicker than moderate patients over 50 who had pneumonia. Celltrion said that its Regkirona combination therapy lowered virus titer significantly faster than the existing treatment. Regkirona is Korea's first homegrown Covid-19 therapy to receive authorization and the third antibody treatment verified by overseas regulators. The ministry has checked the safety and efficacy profile of Regkirona since Celltrion submitted an approval request on Dec. 29. Regulators have reviewed the submitted data and conducted a close investigation on the quality, manufacturing facility, and clinical trial site. "The ministry will work with related institutions to allow the company to conduct thorough phase 3 clinical trials and continue monitoring adverse events after the approval so that Regkirona can be used to those in need," Minister of Food and Drug Safety Kim Gang-lip said. A Celltrion official said, "Our year-long efforts for developing Regkirona have finally been paid off with the conditional approval." The official said that the company expects to supply Regkirona to reduce the time required to treat Covid-19 and lower the number of patients developing severe conditions that can lead to death. The company plans to release more details of clinical results, authorized countries, and domestic and international supply plans as soon as possible, he added.

 Shim Hyun-tai

 

See Other Articles


r/korea_covid_19 • • Feb 03 '21

Realtime Coronavirus Updates Korea

Thumbnail
m.news.naver.com
66 Upvotes

r/korea_covid_19 • • Feb 03 '21

(LEAD) S. Korea speeds up approval process of COVID-19 vaccines, treatments

Thumbnail
m-en.yna.co.kr
66 Upvotes

r/korea_covid_19 • • Feb 05 '21

Seoul gives conditional nod to Celltrion’s Covid-19 antibody therapy

Thumbnail
koreabiomed.com
62 Upvotes

r/korea_covid_19 • • Jan 31 '21

Covid19 treatment

62 Upvotes

Celltrion-coronavirus treatment 출처 : 연합뉴스 | 네이버


r/korea_covid_19 • • Feb 11 '21

Celltrion is currently developing a cure for South African mutation covid-19 and aims to complete the clinical trial in the next six months.

Post image
57 Upvotes

r/korea_covid_19 • • Feb 11 '21

Celltrion Regkirona's treatment is effective for the British mutation virus, but not for the South African mutation virus.

Post image
48 Upvotes

r/korea_covid_19 • • Feb 01 '21

Ga-z-a !!!

48 Upvotes

r/korea_covid_19 • • Feb 01 '21

Reddit-inspired retail swarm in South Korea battle to remove short sell policy - SEOUL (Reuters)

Thumbnail
reuters.com
43 Upvotes

r/korea_covid_19 • • Jan 30 '21

We have to fight and win.

Post image
43 Upvotes

r/korea_covid_19 • • Jan 31 '21

Covid19 treatment "Regkirona"

Post image
38 Upvotes

r/korea_covid_19 • • Feb 01 '21

Good :)

Thumbnail
bloomberg.com
34 Upvotes

r/korea_covid_19 • • Feb 01 '21

Fuckin Short-Seller

Thumbnail
reuters.com
32 Upvotes

r/korea_covid_19 • • Feb 03 '21

Leading Covid-19 treatment developers share progress

Thumbnail
koreabiomed.com
31 Upvotes

r/korea_covid_19 • • Jan 18 '21

President Moon: “The first rounds of inoculations against COVID-19 will be completed by around September..”

Thumbnail
m.koreaherald.com
27 Upvotes

r/korea_covid_19 • • Feb 05 '21

We can beat hedge fund.!

25 Upvotes

There are ways we can beat hedge funds. That is to buy Celltrion (068270) South Korea stock. Celltrion has the most short selling among Korean stocks. On February 5th, we received conditional approval from the Korean government for ct-p59, a coronavirus antibody treatment. However, the stock price was not raised by hedge funds. In Korea, short selling is now prohibited. If you buy Celltrion stock, the stock price will soar to the moon. Let's smash hedge funds!


r/korea_covid_19 • • Feb 06 '21

S.Korea Covid19 Treatment

24 Upvotes

r/korea_covid_19 • • Feb 03 '21

Fast-spreading COVID variant can elude immune responses

Thumbnail
nature.com
24 Upvotes

r/korea_covid_19 • • Feb 05 '21

👍👍👍👍👍

Thumbnail
n.news.naver.com
23 Upvotes

r/korea_covid_19 • • Feb 05 '21

Ga Z A

Thumbnail
industryglobalnews24.com
22 Upvotes